CC Chemokines in a Tumor: A Review of Pro-Cancer and Anti-Cancer Properties of Receptors CCR5, CCR6, CCR7, CCR8, CCR9, and CCR10 Ligands.

Korbecki J, Grochans S, Gutowska I, Barczak K, Baranowska-Bosiacka I. · 2020

Read CC Chemokines in a Tumor: A Review of Pro-Cancer and Anti-Cancer Properties of Receptors CCR5, CCR6, CCR7, CCR8, CCR9, and CCR10 Ligands. by Korbecki J, Grochans S, Gutowska I, Barczak K, Baranowska-Bosiacka I. (2020) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7590012.txt.

Introduction

Korbecki and co-authors review CC chemokines in tumors and their dual effects. Chemokines are signals that guide immune cell movement. The CC group holds 28 such cytokines in humans.

The review focuses on ligands for six receptors. They are CCR5, CCR6, CCR7, CCR8, CCR9 and CCR10. These signals can help or harm in cancer. They affect cancer cell growth, survival and movement. They also affect drug resistance in tumor cells. Cell recruitment to the tumor niche is detailed. Drawn cells include macrophages, suppressor cells and T cells. Effects on blood and lymph vessels are covered. Those effects drive new vessel growth in tumors.

Catalog record

CREATORKorbecki J, Grochans S, Gutowska I, Barczak K, Baranowska-Bosiacka I.
YEAR2020
COLLECTIONPAPERS
FORMATTXT
FILE SIZE115 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC7590012

Browse the full library · About the Tower of Babel